Variable | Total (%) |
---|---|
Sex | |
Male | 25 (69.4) |
Female | 11 (30.6) |
Age | |
> 60 | 21 (58.3) |
≤ 60 | 15 (41.7) |
Smoking status | |
Smkers | 26 (72.2) |
Nonsmkers | 10 (27.8) |
Tumor size | |
> 5 cm | 16 (44.4) |
≤ 5 cm | 20 (55.6) |
Tumor site | |
Left | 18 (50.0) |
Right | 18 (50.0) |
T stage | |
T1 and T2 | 28 (77.8) |
T3 and T4 | 8 (22.2) |
N stage | |
N0 and N1 | 28 (77.8) |
N2 and N3 | 8 (22.2) |
Clinical stage | |
Ia and IIa | 21 (58.3) |
IIb and IIIb | 15 (41.7) |
Pathological type | |
Pleomorphic carcinoma | 31 (86.1) |
other | 5 (13.9) |
Treatment | |
Surgery | 24 (66.7) |
Surgeryand chemotherapy | 12 (33.3) |